Received Jul 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | E5JY2 | — |
Arexvy expired dose administration (less than 30 days); This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 79-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number E5JY2, expiry date 10-JUL-2025) for prophylaxis. On 21-JUL-2025, the patient received Arexvy. On 21-JUL-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: Arexvy expired dose administration (less than 30 days)). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 25-JUL-2025 The pharmacist wanted to get information regarding a maladministration of an expired dose of Arexvy (less than 30 days between the expiration and the administration date) which led to expired vaccine used. The vaccine administration facility was the same as primary reporter.